Filter
91
Filtered Results: 91
Text search:
DNDi
Featured
Recommendations
10
New Publications
9
Language
Document type
Studies & Reports
32
No document type
18
Manuals
7
Guidelines
7
Strategic & Response Plan
7
Resource Platforms
5
Fact sheets
5
Videos
4
Brochures
2
Infographics
2
Training Material
1
Situation Updates
1
Countries / Regions
Global
10
Latin America and the Carribbean
8
Colombia
4
Kenya
2
Africa
2
West and Central Africa
2
East and Southern Africa
2
Brazil
2
Ethiopia
2
Asia
1
Congo, Democratic Republic of
1
South–East Asia Region
1
Southern Africa
1
Bangladesh
1
Uganda
1
Zambia
1
India
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
19
Clinical Guidelines
11
Pharmacy & Technologies
3
Public Health
1
Key Resources
1
Toolboxes
NTDs
59
HIV
6
Global Health Education
3
COVID-19
2
Pharmacy
2
AMR
2
TB
1
Planetary Health
1
Health Financing Toolbox
1
NCDs
1
The Lancet Volume 5, Issue 10100972October 2024 Chagas Disease Serie 3
Localized cutaneous leishmaniasis and its evolving forms (diffuse cutaneous leishmaniasis, mucosal leishmaniasis and cutaneous leishmaniasis recidivans), together with the sequela of visceral leishmaniasis (post-kala-azar dermal leishmaniasis), account for about one million cases of dermal leishmani...
WHO and UNITAID
in collaboration with IMPAACT (International Maternal Pediatric Adolescent AIDS Clinical Trials) network, PENTA (Paediatric European Network for Treatment of AIDS) foundation and experts from the Paediatric Antiretroviral Working Group
Human African trypanosomiasis (HAT), or sleeping sickness, is an endemic disease in 36 sub-Saharan African countries, typically occurring in underdeveloped areas, where
health systems face significant difficulties of diverse natures.
Lessons from the STEP-TB Project.
Accessed November 2017.
Rev Panam Salud Publica 2023;47:e141. https://doi.org/10.26633/RPSP.2023.141
Over 6 million people worldwide are infected with Trypanosoma cruzi, the protozoan that causes Chagas disease
(CD). T. cruzi is transmitted by triatomine insects, congenitally, through uncontrolled blood donations and organ transplants,
and via consumption of food or drink contaminated by triatomi...
Accessed on 22.04.2023
To target helminth elimination, a new consortium of research institutes, universities, not-for-profit organizations, and pharmaceutical companies have joined forces and expertise to establish a research and development pipeline for the development of anthelminthics targeti...
The goal of this Global Action Plan is to articulate synergistic actions that will be required to prevent HIVDR from undermining efforts to achieve global targets on health and HIV, and to provide the most effective treatment to all people living with HIV including adults, key populations, pregnant ...
The growing challenges for people in low and middle-income countries to access new medicines.
Analysis 58
The World Health Organization (WHO) and the global community of countries, partners, donors, technical experts, scientists and field implementation teams continue to work towards the ultimate goal of a world free of the burden of neglected tropical diseases (NTDs).
Rev. Panam Salud Publica. 2017;41:e153. doi: 10.26633/RPSP.2017.153
Worldwide, over 6 million people are infected with Trypanosoma cruzi, the pathogen that causes Chagas disease (CD). In the Americas, CD creates the greatest burden in disability-adjusted life years of any parasitic infection. In Co...
Mem Inst Oswaldo Cruz, Rio de Janeiro, Vol. 117: e200460, 2022
Integrating the multiple dimensions of the problem into a coherent approach adapted to field realities and needs represents an immense challenge, but the payoff is more effective and sustainable experiences, with higher social awareness...
J Glob Health Sci. 2020 Jun;2(1):e3. A group of enzootic and zoonotic protozoan infections, the leishmaniases constitute among the most severely neglected tropical diseases (NTDs) and are found in all continents except Oceania. Representing the most common infectious diseases, NTDs comprise an open-...
This report provides an update on the key facets of HIV treatment access, including the latest HIV treatment guidelines from World Health Organization (WHO), an overview on pricing for first-line, second-line, and salvage regimens, and a summary of the opportunities for – and threats to – expand...
This document focuses on making recommendations for the diagnosis and treatment of Chagas disease, an infection caused by Trypanosoma cruzi, the protozoan agent of a systemic parasitic disease. Methodology: These clinical practice guidelines were prepared following the WHO handbook for guideline dev...
The Lancet Microbe Series Chagas Disease 2 Volume 5, Issue 10100946 October 2024
